NICOTINE METABOLISM IN ISOLATED PERFUSED LUNG AND LIVER OF PHENOBARBITAL-TREATED AND BENZOFLAVONE-TREATED RATS

被引:11
作者
FOTH, H
LOOSCHEN, H
NEURATH, H
KAHL, GF
机构
[1] Department of Pharmacology and Toxicology, University of Göttingen, Göttingen, W-3400
关键词
EXTRAHEPATIC AND HEPATIC METABOLISM; NICOTINE; COTININE; PB INDUCTION;
D O I
10.1007/BF01973505
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The kinetics of nicotine elimination was investigated in isolated perfused lung and liver of phenobartial (PB)-and 5,6-benzoflavone (BF)-pretreated rats. The estimated kinetic parameters demonstrated a high nicotine elimination rate in rat lung approaching the capacity of liver when both organs were in an uninduced state. The concentration-time profiles of cotinine as the main metabolite were almost identical for isolated lung and liver. In both organs the cotinine plasma concentrations reached a plateau level after 60 min of perfusion. Pretreatment of rats with 5,6-benzoflavone did not affect the rate of nicotine elimination and cotinine formation either in the lung or in the liver. Phenobarbital treatment, however, induced nicotine clearance in lung approximately 2-fold. This effect is quantitatively lower than the PB-related 8-fold induction of hepatic nicotine elimination observed in a previous study. The present results also indicate that the turnover of cotinine is markedly enhanced after PB induction. The elimination half-lives and clearance values for cotinine as the substrate were approximately 10-fold increased in rat liver after PB pretreatment. Thus, an important contribution of extrahepatic tissues to nicotine metabolism in rats has to be assumed. Moreover, since cotinine elimination is significantly increased after PB induction it is questionable whether cotinine plasma concentrations can further be used as suitable parameter for nicotine consumption.
引用
收藏
页码:68 / 72
页数:5
相关论文
共 32 条
[1]   ABSORPTION AND METABOLISM OF NICOTINE FROM CIGARETTES [J].
ARMITAGE, AK ;
DOLLERY, CT ;
GEORGE, CF ;
HOUSEMAN, TH ;
LEWIS, PJ ;
TURNER, DM .
BRITISH MEDICAL JOURNAL, 1975, 4 (5992) :313-316
[2]   COTININE DISPOSITION AND EFFECTS [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :604-611
[3]   NICOTINE AND CARBON-MONOXIDE INTAKE FROM HIGH-YIELD AND LOW-YIELD CIGARETTES [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) :265-270
[4]   ENZYMIC OXIDATION OF (-)-NICOTINE BY GUINEA-PIG TISSUES IN-VITRO [J].
BOOTH, J ;
BOYLAND, E .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (02) :407-&
[5]  
BOWMAN ER, 1962, J PHARMACOL EXP THER, V135, P306
[6]   ENZYME ALDEHYDE OXIDASE IS AN IMINIUM OXIDASE - REACTION WITH NICOTINE DELTA-1'(5')IMINIUM ION [J].
BRANDANGE, S ;
LINDBLOM, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 91 (03) :991-996
[7]   STRUCTURE OF HYDROXYCOTININE, A NICOTINE METABOLITE [J].
DAGNE, E ;
CASTAGNOLI, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (04) :356-+
[8]  
FOTH H, 1988, KLIN WOCHENSCHR, V66, P98
[9]   STEADY-STATE CONCENTRATION OF COTININE AS A MEASURE OF NICOTINE-INTAKE BY SMOKERS [J].
GALEAZZI, RL ;
DAENENS, P ;
GUGGER, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) :301-304
[10]  
Gibaldi M, 1982, PHARMACOKINETICS REV, V2nd, P45